![Guidance for Industry](https://public4.pagefreezer.com:443/content/FDA/07-06-2023T13:28/https://www.fda.gov/files/styles/medium_3/public/StandardGuidanceGraphic.png?itok=79PGAmMJ)
FDA issues new draft ICH guidance for Good Clinical Practice
June 6 - Guidance ensures participant safety and reliability of clinical trials
June 6 - Guidance ensures participant safety and reliability of clinical trials
May 31 - These recommendations can improve detection of treatment effects
May 30 - Rule ensures patients receive essential prescription drug information
May 30 - Will look at trial design, use of digital health technologies and more
May 24 - Acinetobacter tops lists of urgent threats needing treatment options
May 24 - Will cover study design considerations and the assessment of food on drugs
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.